河北医药2024,Vol.46Issue(17) :2675-2679,2685.DOI:10.3969/j.issn.1002-7386.2024.17.026

口腔黏膜下纤维性变的治疗研究进展

Research progress of the treatment of oral submucosal fibrous

陈灵 杜永秀 徐普
河北医药2024,Vol.46Issue(17) :2675-2679,2685.DOI:10.3969/j.issn.1002-7386.2024.17.026

口腔黏膜下纤维性变的治疗研究进展

Research progress of the treatment of oral submucosal fibrous

陈灵 1杜永秀 1徐普1
扫码查看

作者信息

  • 1. 570208 海口市,中南大学湘雅医学院附属海口医院海南省口腔医学中心
  • 折叠

摘要

口腔黏膜下纤维性变(OSF)是一种慢性、潜伏性疾病,被归类为口腔潜在恶性疾病,是一个全球性和区域性的公共卫生问题.它被认为是一种多因素疾病,如咀嚼槟榔、微量元素紊乱和遗传易感性等.本文回顾总结近年来国内外治疗OSF的各种方法,包括药物治疗、手术治疗、物理治疗等,以上治疗方法主要是减轻疾病的体征和症状,尚缺乏单一有效的治疗方法.此外,有部分研究者提出新的治疗方法-干细胞治疗,但是观察病例量较少,疗效和安全性有待进一步研究.

Abstract

Oral submucous fibrosis(OSF)is a chronic,latent disease classified as oral potentially malignant disorder,which is a global and regional public health problem.It is considered to be a multifactorial disease,and its inducements include chewing areca nut,micronutrient disorders genetic predisposition,etc.In this paper,various methods for the treatment of OSF in recent years at home and abroad are reviewed and summarized,covering drug therapy,surgical therapy,physical therapy,etc.The above methods are mainly to reduce the symptoms of this disease.The single effective method to treat OSF is still unreported.It is noteworthy that some researchers have proposed a new treatment-Stem cell therapy,while the number of observed cases is small,and its efficacy and safety need to be further studied.

关键词

口腔黏膜下纤维性变/治疗/张口受限/干细胞治疗

Key words

oral submucous fibrosis/treatment/restricted mouth opening/stem cell therapy

引用本文复制引用

基金项目

海南省重大科技计划项目(ZDKJ2021039)

出版年

2024
河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
段落导航相关论文